文献速递生殖医学

胚胎游离DNA与滋养外胚层活检用于非整倍体检测:一致性率及临床意义

Embryonic cell-free DNA versus trophectoderm biopsy for aneuploidy testing: concordance rate and clinical implications.
PubMed 文献 · Fertil Steril · 2019-06-11

这项前瞻性盲法预试验纳入46例患者共115份滋养外胚层活检与囊胚培养液样本,比较胚胎游离DNA与活检在整倍体检测上的一致性。总体一致性率78.7%,灵敏度94.5%、特异度71.7%;第6/7天样本一致性84%。整倍体胚胎且培养液整倍体组的持续种植率为52.9%,高于整倍体胚胎但培养液非整倍体组的16.7%,差异未达统计学显著。

要点

  • 总体倍性与性染色体一致性率78.7%,灵敏度94.5%,特异度71.7%。
  • 第6/7天样本一致性84%,高于第5天样本,各项参数显著提高。
  • 整倍体胚胎且培养液整倍体组持续种植率52.9%,高于培养液非整倍体组16.7%,差异未达显著。

核心结论

  • 结果有助于更好理解胚胎发育过程中游离DNA的动态变化,尽管仍需更多基础研究,但令人安心的是未来可考虑将这种无创方法作为滋养外胚层活检用于PGT-A的替代方案。

研究设计与样本

  • 前瞻性盲法预试验,在体外受精中心与遗传学实验室开展。
  • 纳入46例患者,年龄32至46岁,PGT-A指征为高龄、复发性流产或反复种植失败,共采集115份滋养外胚层活检与囊胚培养液样本。

主要发现

  • 总体倍性与性染色体一致性率为78.7%,灵敏度94.5%,特异度71.7%。
  • 第6/7天样本各项参数较第5天样本显著提高,倍性与性染色体总体一致性84%,灵敏度95.2%,特异度82.1%。
  • 整倍体滋养外胚层且整倍体培养液组的持续种植率为52.9%,整倍体滋养外胚层且非整倍体培养液组为16.7%,前者约为后者的三倍,差异未达统计学显著。
  • 当滋养外胚层与培养液均整倍体一致时未观察到流产。

临床怎么用

  • 作者认为,尽管仍需更多基础研究,未来可考虑将胚胎游离DNA这种无创方法作为滋养外胚层活检用于PGT-A的替代方案。

局限性

  • 原文在结论中写明仍需更多基础研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To study whether embryonic cell-free DNA (cfDNA) in spent blastocyst media is representative of the chromosomal constitution of a blastocyst. DESIGN: Pilot prospective blinded study. SETTING: In vitro fertilization center and genetics laboratory. PATIENT(S): A total of 115 trophectoderm (TE) biopsies and spent blastocyst media (SBM) from 46 patients with ages ranging from 32 to 46 years, whose indications for preimplantation genetic testing of aneuploidy (PGT-A) were advanced maternal age, recurrent miscarriage, or recurrent implantation failure. INTERVENTIONS(S): Spent blastocyst media collection and TE biopsy. MAIN OUTCOME MEASURE(S): Concordance rates, sensitivity, and specificity between TE biopsies and SBM. Clinical outcomes in cases with euploid TE biopsies and euploid SBM compared with cases with euploid TE and aneuploid SBM. RESULT(S): In general, the total concordance rate for ploidy and sex was 78.7%, and sensitivity and specificity were 94.5% and 71.7%, respectively. A significant increase for all parameters was observed for day 6/7 samples compared with day 5 samples, with day 6/7 samples showing total concordance for ploidy and sex of 84%, and sensitivity and specificity of 95.2% and 82.1%, respectively. Ongoing implantation rates in euploid TE/euploid SBM showed a threefold increase compared with euploid TE/aneuploid SBM (52.9% vs. 16.7%, respectively), without reaching significant differences. Interestingly, no miscarriages were observed when TE and SBM were euploidy concordant. CONCLUSION(S): These results offer a better understanding of the dynamics of cfDNA during embryo development and despite more basic research being needed, they are reassuring to consider in the future this noninvasive approach as an alternative to TE biopsy for PGT-A.

来源:Fertil Steril,查看原文。版权归原作者所有。

引用

  1. Rubio C, Rienzi L, Navarro-Sánchez L, et al. Embryonic cell-free DNA versus trophectoderm biopsy for aneuploidy testing: concordance rate and clinical implications. Fertil Steril. 2019. PMID: 31200971. doi:10.1016/j.fertnstert.2019.04.038

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。